VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 155 filers reported holding VENTYX BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 4.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $24,529 | -64.5% | 10,619 | -15.5% | 0.00% | – |
| Q1 2024 | $69,087 | +142.8% | 12,561 | +9.0% | 0.00% | – |
| Q4 2023 | $28,451 | -91.8% | 11,519 | +16.0% | 0.00% | -100.0% |
| Q3 2023 | $344,870 | +6.5% | 9,930 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $323,933 | +40.9% | 9,876 | +43.9% | 0.00% | 0.0% |
| Q1 2023 | $229,877 | -11.2% | 6,862 | -13.1% | 0.00% | 0.0% |
| Q4 2022 | $258,811 | – | 7,893 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 412,225 | $952,240 | 1.81% |
| Octagon Capital Advisors LP | 2,391,114 | $5,523,473 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 3,100,000 | $7,161,000 | 0.73% |
| Opaleye Management Inc. | 1,190,000 | $2,748,900 | 0.63% |
| Sio Capital Management, LLC | 778,924 | $1,799,314 | 0.49% |
| Parkman Healthcare Partners LLC | 1,160,022 | $2,679,651 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,012,749 | $2,339,450 | 0.32% |
| Redmile Group, LLC | 2,164,126 | $4,999,131 | 0.30% |
| WEXFORD CAPITAL LP | 449,046 | $1,037,296 | 0.26% |
| Vestal Point Capital, LP | 1,315,000 | $3,037,650 | 0.23% |